Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)
Clinical trial NCT04783935 · COMPLETED
Trial details
- NCT number
- NCT04783935
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2023-09-21
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.